grant

An in depth analysis of clinical and virological outcomes of 2 strategies for the antiretroviral salvage of first-line regimen virological failure for HIV-1 infection tested in an Australian-led randomised, international, multi-centre clinical trial [ 2014 - 2017 ]

Also known as: An in depth analysis of clinical and virological outcomes in the Australian led 'SECOND-LINE' randomised controlled trial

Funded by National Health and Medical Research Council
Managed by The University of Adelaide
Managed by University of Adelaide
Provided by   National Health and Medical Research Council

Research Grant

[Cite as http://purl.org/au-research/grants/nhmrc/1068383]

Researchers: Prof Mark Boyd (Principal investigator)

Brief description The recently completed Australian-led SECOND-LINE trial is the first high quality study to provide reliable evidence for policy recommendations for the composition of anti-HIV drug cocktails after standard initial treatment has failed. This award will support the researcher in further refining our understanding of how to manage second-line therapy including proposals to test the use of low-cost technologies for application in resource-limited settings where the majority of people with HIV live.

Funding Amount $AUD 421,747.82

Funding Scheme Career Development Fellowships

Notes Clinical CDF

Click to explore relationships graph
Help

Related Organisations

Related People

Related Grants and Projects

Subjects
Clinical Sciences | Infectious Diseases | Medical and Health Sciences | antiretroviral therapy | body composition | bone mineral density | clinical research | collaboration | efficacy | evidence-based clinical practice | human immunodeficiency virus (HIV) | modelling | safety |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA